Literature DB >> 8783390

Chronic lithium attenuates dopamine D1-receptor mediated increases in acetylcholine release in rat frontal cortex.

E Acquas1, H C Fibiger.   

Abstract

The effects of chronic lithium treatment on methylphenidate-, D1 dopamine receptor agonist (A-77636)-, and tactile stimulation-induced increases in frontal cortical acetylcholine release were studied in the rat using in vivo brain microdialysis. Cortical acetylcholine release in control rats was maximally stimulated by methylphenidate (1.25 and 2.5 mg/kg) to 173% and 212% above baseline, respectively. The effect of methylphenidate (2.5 mg/kg) was blocked by pretreatment with the dopamine D1 receptor antagonist SCH 23390 (0.3 mg/kg). Chronic treatment with lithium chloride (3-4 weeks) produced plasma lithium concentrations of 0.45 +/- 0.02 meq/l. Chronic lithium significantly reduced increases in cortical acetylcholine release produced by methylphenidate. Stimulation of dopamine D1 receptors with the full D1 receptor agonist A-77636 (0.73 mg/kg) increased cortical acetylcholine release. Chronic lithium significantly reduced this effect of A-77636. In contrast, lithium failed to influence the increases of cortical acetylcholine release produced by tactile stimulation. These results suggest that while lithium does not influence normal, arousal-related increase in cortical acetylcholine release, this ion selectively attenuates dopamine mediated increases and/or abnormally large increases, which in the present circumstances were pharmacologically induced. The relevance of these findings to the antimanic actions of lithium is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783390     DOI: 10.1007/bf02249415

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

Review 1.  Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium.

Authors:  J M Baraban; P F Worley; S H Snyder
Journal:  Am J Psychiatry       Date:  1989-10       Impact factor: 18.112

2.  Measurement of acetylcholine release in freely moving rats by means of automated intracerebral dialysis.

Authors:  G Damsma; B H Westerink; J B de Vries; C J Van den Berg; A S Horn
Journal:  J Neurochem       Date:  1987-05       Impact factor: 5.372

3.  Increases in hippocampal and frontal cortical acetylcholine release associated with presentation of sensory stimuli.

Authors:  F M Inglis; H C Fibiger
Journal:  Neuroscience       Date:  1995-05       Impact factor: 3.590

4.  The potent and selective dopamine D1 receptor agonist A-77636 increases cortical and hippocampal acetylcholine release in the rat.

Authors:  E Acquas; J C Day; H C Fibiger
Journal:  Eur J Pharmacol       Date:  1994-07-21       Impact factor: 4.432

5.  The pharmacokinetic profile of lithium in rat and mouse; an important factor in psychopharmacological investigation of the drug.

Authors:  A J Wood; G M Goodwin; R De Souza; A R Green
Journal:  Neuropharmacology       Date:  1986-11       Impact factor: 5.250

Review 6.  Recent advances in treatment of acute mania.

Authors:  J C Chou
Journal:  J Clin Psychopharmacol       Date:  1991-02       Impact factor: 3.153

7.  Changes in cortical acetylcholine output induced by modulation of the nucleus basalis.

Authors:  F Casamenti; G Deffenu; A L Abbamondi; G Pepeu
Journal:  Brain Res Bull       Date:  1986-05       Impact factor: 4.077

8.  Enhanced acetylcholine release in hippocampus and cortex during the anticipation and consumption of a palatable meal.

Authors:  F M Inglis; J C Day; H C Fibiger
Journal:  Neuroscience       Date:  1994-10       Impact factor: 3.590

9.  A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets.

Authors:  J W Kebabian; D R Britton; M P DeNinno; R Perner; L Smith; P Jenner; R Schoenleber; M Williams
Journal:  Eur J Pharmacol       Date:  1992-12-15       Impact factor: 4.432

10.  Effects of chronic lithium treatments on central dopaminergic receptor systems: G proteins as possible targets.

Authors:  M Carli; M B Anand-Srivastava; E Molina-Holgado; K M Dewar; T A Reader
Journal:  Neurochem Int       Date:  1994-01       Impact factor: 3.921

View more
  4 in total

1.  3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat.

Authors:  Sunila G Nair; Gary A Gudelsky
Journal:  Psychopharmacology (Berl)       Date:  2005-12-24       Impact factor: 4.530

2.  Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear.

Authors:  E Acquas; C Wilson; H C Fibiger
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

3.  PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics.

Authors:  Tyler Stevens; Katrin Sangkuhl; Jacob T Brown; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2019-08       Impact factor: 2.089

4.  Dopamine D1-like receptor blockade and stimulation decreases operant responding for nicotine and food in male and female rats.

Authors:  Ranjithkumar Chellian; Azin Behnood-Rod; Ryann Wilson; Karen Lin; Grace Wing-Yan King; Marcella Ruppert-Gomez; Alexandria Nicole Teter; Marcelo Febo; Adriaan W Bruijnzeel
Journal:  Sci Rep       Date:  2022-08-19       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.